Bismuth
GET
/api/v1/drug/bismuthMechanism of action
Sourced from openFDAMechanism-of-action class: Acid-Base Activity.
Indications
Sourced from openFDA- Uses: See symptoms on front panel.
Dosage & administration
Sourced from openFDAAdults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Approval history
Sourced from openFDA- Sep 28, 2006NDANDA050786Labs Juvise
- Mar 6, 2023ANDAANDA205770Ph Health
- Jul 3, 2023ANDAANDA217511Ingenus Pharms Llc
Literature
Recent PubMed references pinned to Bismuth as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Boosting CO(2) photoreduction with Ta doped Bi(4)NbO(8)Cl via polarization induced charge separation.Journal of environmental sciences (China) · 2026 · Dian R, Li M, Li Z, et al.PMID 42217899DOI 10.1016/j.jes.2025.07.026
- Mechanistic insights into Fe-BiOBr for enhanced catalytic activation of peroxymonosulfate.Journal of environmental sciences (China) · 2026 · Chen H, Zhou H, Han C, et al.PMID 42217892DOI 10.1016/j.jes.2025.08.046
- N-doped graphene quantum dots decorated NaBiO(3)/BiOBr p-n heterojunction photocatalyst for enhanced visible light degradation of phenol.Journal of environmental sciences (China) · 2026 · Deng J, Zhong M, Chen L, et al.PMID 42217884DOI 10.1016/j.jes.2025.08.048
- Self-supporting BiVO(4)@UiO-66-CdS QD hierarchical scaffold-based heterojunction band alignment for synergistic gain optoelectronic organic transistor sensing.Biosensors & bioelectronics · 2026 · Xie J, Li Y, Liu S, et al.PMID 42184677DOI 10.1016/j.bios.2026.118849
- Oxygen Vacancy-Engineered Hierarchical BiNPs@h-BiOBr Composites Synergized with an MB-Assisted Enzymatic Modulation Strategy for Cathodic Photoelectrochemical Sensing of Penicillin G.Analytical chemistry · 2026 · Peng X, Xu R, Zhang W, et al.PMID 42157577DOI 10.1021/acs.analchem.6c02035
- Z-scheme plasma-catalysis using Ru-doped CeO(2)/Bi(2)O(3) for efficient GenX degradation via oxygen vacancy engineering.Journal of environmental management · 2026 · Ryu B, Wong KT, Lim JS, et al.PMID 42143426DOI 10.1016/j.jenvman.2026.129960
- Efficacy and Safety of Vonoprazan-Based Dual Therapies With Different Antibiotics Versus Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four-Arm, Randomized Controlled Trial.Helicobacter · 2026 · Li J, Li DH, Guo QQ, et al.PMID 42141850DOI 10.1111/hel.70132
- High Eradication Rate of a Potassium-Competitive Acid Blocker-Based Minocycline, Furazolidone, and Bismuth Regimen for Refractory Helicobacter pylori Infection: A Real-World Study.Helicobacter · 2026 · Li JY, Han YY, Li DY, et al.PMID 42141849DOI 10.1111/hel.70128
Clinical trials
The 10 most recently updated of 298 ClinicalTrials.gov registrations naming Bismuth as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric CancerRecruiting · Phase 2 · Interventional · 180 enrolled · Sixth Affiliated Hospital, Sun Yat-sen UniversityNCT06510010updated 2026-06-10
- The Clinical Trail to Evaluate the Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets Combined With Bismuth-containing Quadruple Therapy in Eradicating Helicobacter PyloriNot yet recruiting · Phase 3 · Interventional · 556 enrolled · Xuanzhu Biopharmaceutical Co., Ltd.NCT07606833updated 2026-05-26
- Bismuth Subsalicylate's Role in the Prevention of Travelers' DiarrheaTerminated · Phase 3 · Interventional · 482 enrolled · Centers for Disease Control and PreventionNCT03535272updated 2026-05-22
- Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled TrialCompleted · Interventional · 640 enrolled · Zhongshan Hospital (Xiamen), Fudan UniversityNCT06977841updated 2026-05-19
- Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helicobacter Pylori EradicationNot yet recruiting · Interventional · 90 enrolled · University of Health Sciences LahoreNCT07574983updated 2026-05-08
- Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori EradicationRecruiting · Phase 3 · Interventional · 990 enrolled · National Taiwan University HospitalNCT07576959updated 2026-05-08
- Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori InfectionEnrolling by invitation · Interventional · 66 enrolled · Akil Al IslamNCT07010744updated 2026-05-07
- The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori InfectionRecruiting · Interventional · 600 enrolled · Seoul National University Bundang HospitalNCT02373280updated 2026-04-24
- Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene TestingNot yet recruiting · Interventional · 531 enrolled · Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT07533422updated 2026-04-16
- Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori InfectionRecruiting · Phase 4 · Interventional · 450 enrolled · National Taiwan University HospitalNCT05332444updated 2026-04-15
Frequently asked questions
- How does Bismuth work?
- Mechanism-of-action class: Acid-Base Activity.
- What is Bismuth used for?
- According to FDA labeling, Bismuth carries indications including: Uses: See symptoms on front panel.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Bismuth?
- Bismuth is classified as Acid-Base Activity, Digestive/GI System Activity Alteration.
Note. Data for
bismuth is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.